Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (71-80 of 385) with videos related to

Pageof 39
Sort By:
Bioinformatics (Oxford, England)|February 3, 2016
GiANT: gene set uncertainty in enrichment analysisFlorian Schmid, Matthias Schmid, Christoph Müssel, et al.
Haematologica|September 28, 2023
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activationCarlotta Welters, Marthe-Lina Welters, Serena Stadler, et al.
International Journal of Molecular Sciences|October 13, 2021
Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) PatientsJochen Greiner, Elliott Brown, Lars Bullinger, et al.
Journal of Internal Medicine|May 22, 2022
Application of precision medicine in clinical routine in haematology-Challenges and opportunitiesTove Wästerlid, Lucia Cavelier, Claudia Haferlach, et al.
Cancers|March 14, 2020
Functional Classification of <i>TP53</i> Mutations in Acute Myeloid LeukemiaSayantanee Dutta, Gudrun Pregartner, Frank G Rücker, et al.
Haematologica|December 18, 2009
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrationsFrank Stegelmann, Lars Bullinger, Martin Griesshammer, et al.
Leukemia|May 16, 2019
getITD for FLT3-ITD-based MRD monitoring in AMLTamara J Blätte, Laura K Schmalbrock, Sabrina Skambraks, et al.
Leukemia|April 3, 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
Experimental Hematology|November 12, 2013
Transitory dasatinib-resistant states in KIT(mut) t(8;21) acute myeloid leukemia cells correlate with altered KIT expressionMarkus D Herrmann, Jochen K Lennerz, Lars Bullinger, et al.
Leukemia|April 20, 2022
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
Pageof 39

Showing results (71-80 of 385) with videos related to

Sort By:
Pageof 39
Bioinformatics (Oxford, England)|February 3, 2016
GiANT: gene set uncertainty in enrichment analysisFlorian Schmid, Matthias Schmid, Christoph Müssel, et al.
Haematologica|September 28, 2023
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activationCarlotta Welters, Marthe-Lina Welters, Serena Stadler, et al.
International Journal of Molecular Sciences|October 13, 2021
Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) PatientsJochen Greiner, Elliott Brown, Lars Bullinger, et al.
Journal of Internal Medicine|May 22, 2022
Application of precision medicine in clinical routine in haematology-Challenges and opportunitiesTove Wästerlid, Lucia Cavelier, Claudia Haferlach, et al.
Cancers|March 14, 2020
Functional Classification of <i>TP53</i> Mutations in Acute Myeloid LeukemiaSayantanee Dutta, Gudrun Pregartner, Frank G Rücker, et al.
Haematologica|December 18, 2009
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrationsFrank Stegelmann, Lars Bullinger, Martin Griesshammer, et al.
Leukemia|May 16, 2019
getITD for FLT3-ITD-based MRD monitoring in AMLTamara J Blätte, Laura K Schmalbrock, Sabrina Skambraks, et al.
Leukemia|April 3, 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
Experimental Hematology|November 12, 2013
Transitory dasatinib-resistant states in KIT(mut) t(8;21) acute myeloid leukemia cells correlate with altered KIT expressionMarkus D Herrmann, Jochen K Lennerz, Lars Bullinger, et al.
Leukemia|April 20, 2022
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
Pageof 39